Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTRANSDERMALStandard

COMBIPATCH

ESTRADIOL; NORETHINDRONE ACETATE

Standard Dose
0.05MG/24HR;0.14MG/24HR
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview COMBIPATCH is listed in Drugs@FDA under application 020870 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ESTRADIOL; NORETHINDRONE ACETATE Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR Sponsor NOVEN PHARMS INC Submission history Latest submission status date: 2024-02-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview COMBIPATCH is listed in Drugs@FDA under application 020870 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ESTRADIOL; NORETHINDRONE ACETATE Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR Sponsor NOVEN PHARMS INC Submission history Latest submission status date: 2024-02-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.